
|Articles|September 17, 2021
AJMC® in the Press, September 17, 2021
Author(s)AJMC Staff
Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.
Advertisement
A daily news roundup by
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Most Favored Nation Drug Pricing Moves Forward, but Experts Warn Details Are Still Missing
2
Explore the Clinical Data for JOURNAVX® (suzetrigine)
3
Oncology Landscape Continues to Evolve With Expanded Indications, First-in-Class Therapies
4
FDA Approves Lumateperone as Add-On Therapy for Major Depressive Disorder
5















































